(Q53582013)

English

Pitavastatin inhibits lysophosphatidic acid-induced proliferation and monocyte chemoattractant protein-1 expression in aortic smooth muscle cells by suppressing Rac-1-mediated reactive oxygen species generation.

scientific article published on 14 November 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

Pitavastatin inhibits lysophosphatidic acid-induced proliferation and monocyte chemoattractant protein-1 expression in aortic smooth muscle cells by suppressing Rac-1-mediated reactive oxygen species generation. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

reactive oxygen species

1 reference

based on heuristic

inferred from title

author name string

Utako Kaneyuki

1

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

Seiji Ueda

2

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

Sho-ichi Yamagishi

3

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

Seiya Kato

4

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

Toshiko Fujimura

5

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

Ryo Shibata

6

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

Ayako Hayashida

7

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

Junko Yoshimura

8

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

Masamichi Kojiro

9

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

Koichi Oshima

10

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

Seiya Okuda

11

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

publication date

14 November 2006

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

number of pages

7

1 reference

based on heuristic

inferred from page(s)

Vascular Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

46

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

4

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

286-292

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

Current molecular models for NADPH oxidase regulation by Rac GTPase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Vascular NADPH oxidases: molecular mechanisms of activation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Cellular adhesion molecules on vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Convergence of redox-sensitive and mitogen-activated protein kinase signaling pathways in tumor necrosis factor-alpha-mediated monocyte chemoattractant protein-1 induction in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

AGEs activate mesangial TGF-beta-Smad signaling via an angiotensin II type I receptor interaction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Regulation of mitogen-activated protein kinase cascades by low density lipoprotein and lysophosphatidic acid

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Rac regulates cardiovascular superoxide through diverse molecular interactions: more than a binary GTP switch

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Role of oxidative stress in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Pigment epithelium-derived factor prevents advanced glycation end products-induced monocyte chemoattractant protein-1 production in microvascular endothelial cells by suppressing intracellular reactive oxygen species generation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Lysophospholipids and the cardiovascular system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Coordinate regulation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 expression in human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Vascular smooth muscle migration and proliferation in response to lysophosphatidic acid (LPA) is mediated by LPA receptors coupling to Gq

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

NK-104, a newly developed HMG-CoA reductase inhibitor, suppresses neointimal thickening by inhibiting smooth muscle cell growth and fibronectin production in balloon-injured rabbit carotid artery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Lysophospholipids increase ICAM-1 expression in HUVEC through a Gi- and NF-kappaB-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Oxygen free radical release in human failing myocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-kappaB and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Monocyte chemoattractant protein-1 in human atheromatous plaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Lysophosphatidic acid synthesis and release

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin. Evidence that p47(phox) may participate in forming this oxidase in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Subtype-selective antagonists of lysophosphatidic Acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Lysophosphatidic acid and intracellular signalling in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Plaque rupture, lysophosphatidic acid, and thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Reactive oxygen species in the vasculature: molecular and cellular mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Calcitonin receptor isoforms expressed in the developing rat kidney

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Cellular antioxidant effects of atorvastatin in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Minodronate, a newly developed nitrogen-containing bisphosphonate, suppresses melanoma growth and improves survival in nude mice by blocking vascular endothelial growth factor signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Pigment epithelium-derived factor inhibits TNF-alpha-induced interleukin-6 expression in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen species generation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Inhibitory efficacy of pitavastatin on the early inflammatory response and neointimal thickening in a porcine coronary after stenting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

Characterization of rac and cdc42 activation in chemoattractant-stimulated human neutrophils using a novel assay for active GTPases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.11.002

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VPH.2006.11.002

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17178255

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53582013&oldid=1768524948"